Display options
Share it on

Oncotarget. 2017 May 25;8(35):58003-58020. doi: 10.18632/oncotarget.18217. eCollection 2017 Aug 29.

Trans-sialidase-based vaccine candidate protects against .

Oncotarget

Estefanía Prochetto, Carolina Roldán, Iván A Bontempi, Daiana Bertona, Luz Peverengo, Miguel H Vicco, Luz M Rodeles, Ana R Pérez, Iván S Marcipar, Gabriel Cabrera

Affiliations

  1. Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina.
  2. Facultad de Ciencias Médicas, Universidad Nacional del Litoral, Santa Fe, Argentina.
  3. IDICER-CONICET and Instituto de Inmunología, Facultad de Ciencias Médicas, Universidad Nacional de Rosario, Santa Fe, Argentina.

PMID: 28938533 PMCID: PMC5601629 DOI: 10.18632/oncotarget.18217

Abstract

Prophylactic and/or therapeutic vaccines have an important potential to control

Keywords: Immune response; Immunity; Immunology and Microbiology Section; Trypanosoma cruzi; foxp3 regulatory T cells; myeloid-derived suppressor cells; trans-sialidase; vaccine

Conflict of interest statement

CONFLICTS OF INTEREST None of the authors have a conflict of interest in relation to the content of the present work.

References

  1. J Infect Dis. 2002 Aug 1;186(3):397-404 - PubMed
  2. Infect Immun. 1999 Aug;67(8):3855-63 - PubMed
  3. Hum Vaccin. 2011 Nov;7(11):1184-91 - PubMed
  4. Infect Immun. 2007 Feb;75(2):861-9 - PubMed
  5. Front Microbiol. 2016 Mar 23;7:348 - PubMed
  6. Hum Vaccin Immunother. 2016;12 (2):438-50 - PubMed
  7. Expert Rev Vaccines. 2012 Sep;11(9):1043-55 - PubMed
  8. Int Immunol. 2002 Oct;14(10):1125-34 - PubMed
  9. Am Heart J. 1994 Jan;127(1):151-62 - PubMed
  10. J Biomed Biotechnol. 2007;2007(6):90520 - PubMed
  11. Infect Immun. 2008 Nov;76(11):5191-9 - PubMed
  12. J Immunol. 2010 Feb 15;184(4):2038-47 - PubMed
  13. J Immunol. 2005 Dec 1;175(11):7264-73 - PubMed
  14. Eur J Immunol. 2014 Jan;44(1):184-94 - PubMed
  15. Microbes Infect. 2007 Jul;9(8):1011-9 - PubMed
  16. Infect Immun. 2002 Dec;70(12):6715-25 - PubMed
  17. Front Microbiol. 2014 Sep 11;5:477 - PubMed
  18. Microbes Infect. 2004 Jul;6(8):745-51 - PubMed
  19. N Engl J Med. 2015 Oct;373(14 ):1295-306 - PubMed
  20. Immunobiology. 2012 Aug;217(8):768-77 - PubMed
  21. Blood. 2008 Apr 15;111(8):4233-44 - PubMed
  22. Biochem Biophys Res Commun. 1999 Aug 27;262(2):549-56 - PubMed
  23. Cell Microbiol. 2006 Jul;8(7):1086-95 - PubMed
  24. Infect Immun. 2015 May;83(5):2099-108 - PubMed
  25. PLoS Pathog. 2016 Apr 08;12(4):e1005559 - PubMed
  26. J Immunol. 2008 Oct 15;181(8):5791-802 - PubMed
  27. Anal Biochem. 2011 Mar 15;410(2):310-2 - PubMed
  28. Mem Inst Oswaldo Cruz. 2007 Oct 30;102 Suppl 1:75-85 - PubMed
  29. PLoS Pathog. 2015 May 07;11(5):e1004828 - PubMed
  30. PLoS Pathog. 2016 Sep 19;12(9):e1005896 - PubMed
  31. PLoS Negl Trop Dis. 2011;5(5):e992 - PubMed
  32. Microbes Infect. 2008 Jun;10(7):825-33 - PubMed
  33. J Immunol. 2007 Nov 15;179(10):6889-900 - PubMed
  34. Microbes Infect. 2008 May;10(6):680-8 - PubMed
  35. Vaccine. 2008 May 2;26(19):2322-34 - PubMed
  36. Mem Inst Oswaldo Cruz. 2010 Aug;105(5):687-91 - PubMed
  37. Infect Immun. 2004 Jan;72(1):46-53 - PubMed
  38. Braz J Med Biol Res. 1999 Feb;32(2):235-9 - PubMed
  39. J Immunol Res. 2015;2015:489758 - PubMed
  40. Cell Microbiol. 2012 Oct;14(10):1522-30 - PubMed
  41. Brain Behav Immun. 2015 Mar;45:219-32 - PubMed
  42. Expert Rev Vaccines. 2009 Jul;8(7):921-35 - PubMed
  43. J Neurosci Res. 2013 Oct;91(10):1292-302 - PubMed
  44. PLoS One. 2010 Mar 24;5(3):e9852 - PubMed
  45. Vaccine. 2015 Mar 3;33(10):1274-83 - PubMed
  46. J Leukoc Biol. 2012 Nov;92(5):987-97 - PubMed
  47. Am J Transplant. 2013 Dec;13(12):3123-31 - PubMed
  48. Vet Res. 2013 Mar 11;44:15 - PubMed
  49. Wkly Epidemiol Rec. 2015 Feb 6;90(6):33-43 - PubMed
  50. Microb Cell Fact. 2011 May 14;10:32 - PubMed

Publication Types